[HTML][HTML] Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis
Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …
Artificially intelligent chatbots in digital mental health interventions: a review
EM Boucher, NR Harake, HE Ward… - Expert Review of …, 2021 - Taylor & Francis
Introduction Increasing demand for mental health services and the expanding capabilities of
artificial intelligence (AI) in recent years has driven the development of digital mental health …
artificial intelligence (AI) in recent years has driven the development of digital mental health …
[HTML][HTML] Prevalence and outcomes of frailty in unplanned hospital admissions: a systematic review and meta-analysis of hospital-wide and general (internal) medicine …
Background Guidelines recommend routine frailty screening for all hospitalised older adults
to inform care decisions, based mainly on studies in elective or speciality-specific settings …
to inform care decisions, based mainly on studies in elective or speciality-specific settings …
[HTML][HTML] Randomized trial of TAS-102 for refractory metastatic colorectal cancer
…, Y Komatsu, A Sobrero, E Boucher… - … England Journal of …, 2015 - Mass Medical Soc
Background Early clinical trials conducted primarily in Japan have shown that TAS-102, an
oral agent that combines trifluridine and tipiracil hydrochloride, was effective in the treatment …
oral agent that combines trifluridine and tipiracil hydrochloride, was effective in the treatment …
[HTML][HTML] Near-real-time monitoring of global CO2 emissions reveals the effects of the COVID-19 pandemic
The COVID-19 pandemic is impacting human activities, and in turn energy use and carbon
dioxide (CO2) emissions. Here we present daily estimates of country-level CO2 emissions …
dioxide (CO2) emissions. Here we present daily estimates of country-level CO2 emissions …
[PDF][PDF] Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III …
…, T Decaens, JL Raoul, E Boucher… - Journal of Clinical …, 2013 - researchgate.net
Purpose Brivanib is a selective dual inhibitor of vascular endothelial growth factor and
fibroblast growth factor receptors implicated in tumorigenesis and angiogenesis in …
fibroblast growth factor receptors implicated in tumorigenesis and angiogenesis in …
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study
…, J Heo, J Xu, L Lu, Y Chao, E Boucher… - Journal of clinical …, 2013 - ascopubs.org
Purpose Brivanib is a dual inhibitor of vascular-endothelial growth factor and fibroblast
growth factor receptors that are implicated in the pathogenesis of hepatocellular carcinoma …
growth factor receptors that are implicated in the pathogenesis of hepatocellular carcinoma …
[HTML][HTML] Yttrium‐90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study
Conclusions Despite clear relationships between HBV RNA and HBcrAg levels and CHB
phases, these markers have limited additional value in differentiating CHB phases because …
phases, these markers have limited additional value in differentiating CHB phases because …
Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study
…, C Lombard-Bohas, E Boucher… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE No standard adjuvant treatment currently is recommended in localized biliary
tract cancer (BTC) after surgical resection. We aimed to assess whether gemcitabine and …
tract cancer (BTC) after surgical resection. We aimed to assess whether gemcitabine and …
[HTML][HTML] First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE …
…, J Balosso, A Beny, D Bloomgarden, E Boucher… - The Lancet …, 2017 - thelancet.com
Background Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …